CVS Health tops 4Q forecasts, reaffirms 2022 outlook

Published date09 February 2022
Publication titleThe China Post

COVID-19 vaccines and tests for the virus helped push CVS Health past fourth-quarter expectations.

But the drugstore chain and pharmacy benefits manager did not raise the 2022 forecast it laid out in December, and shares slid in early-morning trading Wednesday.

CVS Health Corp. posted adjusted earnings of $1.98 per share in the final quarter of 2021, as total revenue grew 10% to $76.6 billion.

Analysts expected earnings of $1.83 per share on $75.66 billion in revenue, according to FactSet.

CVS Health said in December that it expected adjusted earnings of $8.10 to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT